Hot Features
Premium
Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Período:
Tipo de Línea:
| Volume | 17,307 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 3.14 | Mínimo Máximo |
|||||
| Minimo del Dia | 3.00 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| NeuroBo Pharmaceuticals Inc | NRBO | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.04 | 1.31% | 3.10 | 23:00:07 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 3.07 | 3.00 | 3.14 | 3.14 | 3.06 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 209 | 17,307 | US$ 3.08 | US$ 53,366 | - | 2.8888 - 6.7499 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 16:59:35 | 5 | US$ 3.10 | USD |
Información Financiera NeuroBo Pharmaceuticals Inc NRBO
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 15.23M | 4.85M | - | 0 | -12.47M | -2.57 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre NeuroBo Pharmaceuticals Inc NRBO
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 17/4/2024 | 07:05 | PR Newswire (US) | NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1.. |
| 01/4/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Completes Enrollment of Part 1 of.. |
| 28/3/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Reports Year End 2023 Financial.. |
| 13/3/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Receives Safety Review Committee.. |
| 04/3/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Appoints Seasoned Life Science.. |
| 04/3/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 29/2/2024 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 29/2/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Receives First Site IRB Approval for.. |
| 14/2/2024 | 07:52 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/2/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals to Participate in the BIO CEO &.. |
| 01/2/2024 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01/2/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a.. |
Histórico de Datos NRBO
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.44 | 3.4999 | 2.99 | 3.12 | 25,444 | -0.34 | -9.88% |
| 1 Month | 4.12 | 4.33 | 2.99 | 3.55 | 25,579 | -1.02 | -24.76% |
| 3 Months | 5.53 | 6.7499 | 2.99 | 5.23 | 257,064 | -2.43 | -43.94% |
| 6 Months | 3.44 | 6.7499 | 2.90 | 5.32 | 708,518 | -0.34 | -9.88% |
| 1 Year | 5.36 | 6.7499 | 2.8888 | 5.01 | 498,882 | -2.26 | -42.16% |
| 3 Years | 849.60 | 1,576.80 | 2.8888 | 253.14 | 1,069,385 | -846.50 | -99.64% |
| 5 Years | 2,196.00 | 7,200.00 | 2.8888 | 312.96 | 775,123 | -2,192.90 | -99.86% |
